- Latest available (Revised) - English
- Latest available (Revised) - Welsh
- Original (As made) - English
- Original (As made) - Welsh
There are currently no known outstanding effects for the The Genetically Modified Food and Feed (Authorisations and Modifications of Authorisations) (Wales) Regulations 2023.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
1.—(1) The title of these Regulations is the Genetically Modified Food and Feed (Authorisations and Modifications of Authorisations) (Wales) Regulations 2023.
(2) These Regulations—
(a)extend to England and Wales;
(b)apply in relation to Wales;
(c)come into force on 26 April 2023.
Commencement Information
I1Reg. 1 in force at 26.4.2023, see reg. 1(2)(c)
2.—(1) In these Regulations—
“Regulation 1829/2003” (“Rheoliad 1829/2003”) means Regulation (EC) No 1829/2003 of the European Parliament and of the Council on genetically modified food and feed;
“Regulation 1830/2003” (“Rheoliad 1830/2003”) means Regulation (EC) No 1830/2003 of the European Parliament and of the Council concerning the traceability and labelling of genetically modified organisms and the traceability of food and feed products produced from genetically modified organisms and amending Directive 2001/18/EC(1);
“Decision 2009/770” (“Penderfyniad 2009/770”) means Commission Decision 2009/770/EC establishing standard reporting formats for presenting the monitoring results of the deliberate release into the environment of genetically modified organisms, as or in products, for the purpose of placing on the market(2).
(2) Expressions used in these Regulations and in Regulation 1829/2003 have the same meaning as in that Regulation.
Commencement Information
I2Reg. 2 in force at 26.4.2023, see reg. 1(2)(c)
3.—(1) Schedules 1 to 7 contain authorisations for products containing, consisting of, or produced from genetically modified organisms.
(2) Schedule 8 contains an authorisation for products containing or consisting of a genetically modified organism.
(3) Subject to Articles 11(4) and 23(4) of Regulation 1829/2003, the authorisations in Schedules 1 to 8 expire at the end of 25 April 2033.
Commencement Information
I3Reg. 3 in force at 26.4.2023, see reg. 1(2)(c)
4.—(1) Commission Decision 2011/891/EU authorising the placing on the market of products containing, consisting of, or produced from genetically modified cotton 281-24-236x3006-210-23 (DAS-24236-5xDAS-21Ø23-5) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council(3) is amended as follows.
(2) In Article 6 (authorisation holder), for the text substitute—
“The authorisation holder is Corteva Agriscience LLC, United States of America, represented in Great Britain by Corteva Agriscience UK Limited.”
(3) In Article 8 (addressee), for the text substitute—
“This Decision is addressed to Corteva Agriscience LLC, 9330 Zionsville Road, Indianapolis, Indiana 46268-1054, United States of America, represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, CB21 5XE, United Kingdom.”
(4) In the Annex, for point (a) (applicant and authorisation holder) substitute—
“(a) Authorisation holder
(1) The authorisation holder is Corteva Agriscience LLC, 9330 Zionsville Road, Indianapolis, Indiana 46268-1054, United States of America.
(2) The authorisation holder is represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, CB21 5XE, United Kingdom.”
Commencement Information
I4Reg. 4 in force at 26.4.2023, see reg. 1(2)(c)
5.—(1) Commission Implementing Decision 2012/84/EU authorising the placing on the market of products containing, consisting of, or produced from genetically modified soybean 356043 (DP-356Ø43-5) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council(4) is amended as follows.
(2) In Article 6 (authorisation holder), for the text substitute—
“The authorisation holder is Corteva Agriscience LLC, United States of America, represented in Great Britain by Corteva Agriscience UK Limited.”
(3) In Article 8 (addressee), for the text substitute—
“This Decision is addressed to Corteva Agriscience LLC, 9330 Zionsville Road, Indianapolis, Indiana 46268-1054, United States of America, represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, CB21 5XE, United Kingdom.”
(4) In the Annex, for point (a) (applicant and authorisation holder) substitute—
“(a) Authorisation holder
(1) The authorisation holder is Corteva Agriscience LLC, 9330 Zionsville Road, Indianapolis, Indiana 46268-1054, United States of America.
(2) The authorisation holder is represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, CB21 5XE, United Kingdom.”
Commencement Information
I5Reg. 5 in force at 26.4.2023, see reg. 1(2)(c)
6.—(1) Commission Implementing Decision 2013/648/EU authorising the placing on the market of products containing, consisting of, or produced from genetically modified maize MON89034 × 1507 × NK603 (MON-89Ø34-3 × DAS-Ø15Ø7-1 × MON-ØØ6Ø3-6) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council(5) is amended as follows.
(2) In Article 6 (authorisation holders), for paragraph (1) substitute—
“(1) The authorisation holders are:
(a)Corteva Agriscience LLC, United States of America, represented in Great Britain by Corteva Agriscience UK Limited, and
(b)Bayer CropScience LP, United States of America, represented in Great Britain by Bayer CropScience Limited.”
(3) In Article 8 (addressees), for the text substitute—
“This Decision is addressed to:
(a)Corteva Agriscience LLC, 9330 Zionsville Road, Indianapolis, Indiana 46268-1054, United States of America, represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, CB21 5XE, United Kingdom, and
(b)Bayer CropScience LP, 800 N. Lindbergh Boulevard, St. Louis, Missouri 63167, United States of America, represented in Great Britain by Bayer CropScience Limited, 230 Cambridge Science Park, Milton Road, Cambridge, CB4 0WB, United Kingdom.”
(4) In the Annex, for point (a) (applicants and authorisation holders) substitute—
“(a) Authorisation holders
(1) Corteva Agriscience LLC, 9330 Zionsville Road, Indianapolis, Indiana 46268-1054, United States of America, represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, CB21 5XE, United Kingdom, and
(2) Bayer CropScience LP, 800 N. Lindbergh Boulevard, St. Louis, Missouri 63167, United States of America, represented in Great Britain by Bayer CropScience Limited, 230 Cambridge Science Park, Milton Road, Cambridge, CB4 0WB, United Kingdom.”
Commencement Information
I6Reg. 6 in force at 26.4.2023, see reg. 1(2)(c)
7.—(1) Commission Implementing Decision 2013/650/EU authorising the placing on the market of products containing, consisting of, or produced from genetically modified (GM) maize MON 89034 × 1507 × MON88017 × 59122 (MON-89Ø34-3 × DAS-Ø15Ø7-1 × MON-88Ø17-3 × DAS-59122-7), four related GM maizes combining three different single GM events (MON89034 × 1507 × MON88017 (MON-89Ø34-3 × DAS-Ø15Ø7-1 × MON-88Ø17-3), MON89034 × 1507 × 59122 (MON-89Ø34-3 × DAS-Ø15Ø7-1 × DAS-59122-7), MON89034 × MON88017 × 59122 (MON-89Ø34-3 × MON-88Ø17-3 × DAS-59122-7), 1507 × MON 88017 × 59122 (DAS-Ø15Ø7-1 × MON-88Ø17-3 × DAS-59122-7)) and four related GM maizes combining two different single GM events (MON89034 × 1507 (MON-89Ø34-3 × DAS-Ø15Ø7-1), MON89034 × 59122 (MON-89Ø34-3 × DAS-59122-7), 1507 × MON88017 (DAS-Ø15Ø7-1 × MON-88Ø17-3), MON 88017 × 59122 (MON-88Ø17-3 × DAS-59122-7)) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council(6) is amended as follows.
(2) In Article 6 (authorisation holders), for paragraph (1) substitute—
“(1) The authorisation holders are:
(a)Corteva Agriscience LLC, United States of America, represented in Great Britain by Corteva Agriscience UK Limited, and
(b)Bayer CropScience LP, United States of America, represented in Great Britain by Bayer CropScience Limited.”
(3) In Article 8 (addressees), for the text substitute—
“This Decision is addressed to:
(a)Corteva Agriscience LLC, 9330 Zionsville Road, Indianapolis, Indiana 46268-1054, United States of America, represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, CB21 5XE, United Kingdom, and
(b)Bayer CropScience LP, 800 N. Lindbergh Boulevard, St. Louis, Missouri 63167, United States of America, represented in Great Britain by Bayer CropScience Limited, 230 Cambridge Science Park, Milton Road, Cambridge, CB4 0WB, United Kingdom.”
(4) In the Annex, for point (a) (applicant and authorisation holders) substitute—
“(a) Authorisation holders
(1) Corteva Agriscience LLC, 9330 Zionsville Road, Indianapolis, Indiana 46268-1054, United States of America, represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, CB21 5XE, United Kingdom, and
(2) Bayer CropScience LP, 800 N. Lindbergh Boulevard, St. Louis, Missouri 63167, United States of America, represented in Great Britain by Bayer CropScience Limited, 230 Cambridge Science Park, Milton Road, Cambridge, CB4 0WB, United Kingdom.”
Commencement Information
I7Reg. 7 in force at 26.4.2023, see reg. 1(2)(c)
8.—(1) Commission Implementing Decision (EU) 2015/698 authorising the placing on the market of products containing, consisting of, or produced from genetically modified soybean 305423 (DP-3Ø5423-1) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council(7) is amended as follows.
(2) In Article 7 (authorisation holder), for the text substitute—
“The authorisation holder is Corteva Agriscience LLC, United States of America, represented in Great Britain by Corteva Agriscience UK Limited.”
(3) In Article 9 (addressee), for the text substitute—
“This Decision is addressed to Corteva Agriscience LLC, 9330 Zionsville Road, Indianapolis, Indiana 46268-1054, United States of America, represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, CB21 5XE, United Kingdom.”
(4) In the Annex, for point (a) (applicant and authorisation holder) substitute—
“(a) Authorisation holder
(1) The authorisation holder is Corteva Agriscience LLC, 9330 Zionsville Road, Indianapolis, Indiana 46268-1054, United States of America.
(2) The authorisation holder is represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, CB21 5XE, United Kingdom.”
Commencement Information
I8Reg. 8 in force at 26.4.2023, see reg. 1(2)(c)
9.—(1) Commission Implementing Decision (EU) 2016/1215 authorising the placing on the market of products containing, consisting of, or produced from genetically modified soybean FG72 (MST-FGØ72-2) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council(8) is amended as follows.
(2) In Article 6 (authorisation holder), for the text substitute—
“The authorisation holder is Syngenta Crop Protection AG, Switzerland, represented in Great Britain by Syngenta Limited.”
(3) In Article 8 (addressee), for the text substitute—
“This Decision is addressed to Syngenta Crop Protection AG, Rosentalstrasse 67, CH-4058 Basel, Switzerland, represented in Great Britain by Syngenta Limited, Jealott’s Hill International Research Centre, Bracknell, Berkshire, RG42 6EY, United Kingdom.”
(4) In the Annex, for point (a) (applicant and authorisation holder) substitute—
“(a) Authorisation holder:
(1) The authorisation holder is Syngenta Crop Protection AG, Rosentalstrasse 67, CH-4058 Basel, Switzerland.
(2) The authorisation holder is represented in Great Britain by Syngenta Limited, Jealott’s Hill International Research Centre, Bracknell, Berkshire, RG42 6EY, United Kingdom.”
Commencement Information
I9Reg. 9 in force at 26.4.2023, see reg. 1(2)(c)
10.—(1) Commission Implementing Decision (EU) 2017/1211 authorising the placing on the market of products containing, consisting of, or produced from genetically modified cotton 281-24-236 × 3006-210-23 × MON 88913 (DAS-24236-5 × DAS-21Ø23-5 × MON-88913-8) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council(9) is amended as follows.
(2) In Article 6 (authorisation holder), for the text substitute—
“The authorisation holder is Corteva Agriscience LLC, United States of America, represented in Great Britain by Corteva Agriscience UK Limited.”
(3) In Article 8 (addressee), for the text substitute—
“This Decision is addressed to Corteva Agriscience LLC, 9330 Zionsville Road, Indianapolis, Indiana 46268-1054, United States of America, represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, CB21 5XE, United Kingdom.”
(4) In the Annex, for point (a) (applicant and authorisation holder) substitute—
“(a) Authorisation holder:
(1) The authorisation holder is Corteva Agriscience LLC, 9330 Zionsville Road, Indianapolis, Indiana 46268-1054, United States of America.
(2) The authorisation holder is represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, CB21 5XE, United Kingdom.”
Commencement Information
I10Reg. 10 in force at 26.4.2023, see reg. 1(2)(c)
11.—(1) Commission Implementing Decision (EU) 2017/1212 authorising the placing on the market of products containing, consisting of, or produced from genetically modified maize DAS-40278-9, pursuant to Regulation (EC) No 1829/2003 of the European parliament and of the Council on genetically modified food and feed(10) is amended as follows.
(2) In Article 6 (authorisation holder), for the text substitute—
“The authorisation holder is Corteva Agriscience LLC, United States of America, represented in Great Britain by Corteva Agriscience UK Limited.”
(3) In Article 8 (addressee), for the text substitute—
“This Decision is addressed to Corteva Agriscience LLC, 9330 Zionsville Road, Indianapolis, Indiana 46268-1054, United States of America, represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, CB21 5XE, United Kingdom.”
(4) In the Annex, for point (a) (authorisation holder) substitute—
“(a) Authorisation holder:
(1) The authorisation holder is Corteva Agriscience LLC, 9330 Zionsville Road, Indianapolis, Indiana 46268-1054, United States of America.
(2) The authorisation holder is represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, CB21 5XE, United Kingdom.”
Commencement Information
I11Reg. 11 in force at 26.4.2023, see reg. 1(2)(c)
12.—(1) Commission Implementing Decision (EU) 2017/2448 authorising the placing on the market of products containing, consisting of, or produced from genetically modified soybean 305423 × 40-3-2 (DP-3Ø5423-1 × MON-Ø4Ø32-6) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council on genetically modified food and feed(11) is amended as follows.
(2) In Article 7 (authorisation holder), for the text substitute—
“The authorisation holder is Corteva Agriscience LLC, United States of America, represented in Great Britain by Corteva Agriscience UK Limited.”
(3) In Article 9 (addressee), for the text substitute—
“This Decision is addressed to Corteva Agriscience LLC, 9330 Zionsville Road, Indianapolis, Indiana 46268-1054, United States of America, represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, CB21 5XE, United Kingdom.”
(4) In the Annex, for point (a) (applicant and authorisation holder) substitute—
“(a) Authorisation holder:
(1) The authorisation holder is Corteva Agriscience LLC, 9330 Zionsville Road, Indianapolis, Indiana 46268-1054, United States of America.
(2) The authorisation holder is represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, CB21 5XE, United Kingdom.”
Commencement Information
I12Reg. 12 in force at 26.4.2023, see reg. 1(2)(c)
13.—(1) Commission Implementing Decision (EU) 2017/2449 authorising the placing on the market of products containing, consisting of, or produced from genetically modified soybean DAS-68416-4, pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council on genetically modified food and feed(12) is amended as follows.
(2) In Article 7 (authorisation holder), for the text substitute—
“The authorisation holder is Corteva Agriscience LLC, United States of America, represented in Great Britain by Corteva Agriscience UK Limited.”
(3) In Article 9 (addressee), for the text substitute—
“This Decision is addressed to Corteva Agriscience LLC, 9330 Zionsville Road, Indianapolis, Indiana 46268-1054, United States of America, represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, CB21 5XE, United Kingdom.”
(4) In the Annex, for point (a) (authorisation holder) substitute—
“(a) Authorisation holder:
(1) The authorisation holder is Corteva Agriscience LLC, 9330 Zionsville Road, Indianapolis, Indiana 46268-1054, United States of America.
(2) The authorisation holder is represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, CB21 5XE, United Kingdom.”
Commencement Information
I13Reg. 13 in force at 26.4.2023, see reg. 1(2)(c)
14.—(1) Commission Implementing Decision (EU) 2017/2450 authorising the placing on the market of products containing, consisting of, or produced from genetically modified soybean DAS-44406-6, pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council on genetically modified food and feed(13) is amended as follows.
(2) In Article 7 (authorisation holder)—
(a)for the heading substitute—
(b)for the text substitute—
“The authorisation holders are Corteva Agriscience LLC, United States of America, and M.S. Technologies LLC, United States of America, both represented in Great Britain by Corteva Agriscience UK Limited.”
(3) In Article 9 (addressee)—
(a)for the heading substitute—
(b)for the text substitute—
“This Decision is addressed to Corteva Agriscience LLC, 9330 Zionsville Road, Indianapolis, Indiana 46268-1054, United States of America, and to M.S. Technologies LLC, 103 Avenue D, West Point, IA 52656, United States of America, both represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, CB21 5XE, United Kingdom.”
(4) In the Annex, for point (a) (authorisation holder) substitute—
“(a) Authorisation holders:
(1) The authorisation holders are—
Corteva Agriscience LLC, 9330 Zionsville Road, Indianapolis, Indiana 46268-1054, United States of America, and
M.S. Technologies LLC, 103 Avenue D, West Point, IA 52656, United States of America.
(2) Both authorisation holders are represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, CB21 5XE, United Kingdom.”
Commencement Information
I14Reg. 14 in force at 26.4.2023, see reg. 1(2)(c)
15.—(1) Commission Implementing Decision (EU) 2017/2452 renewing the authorisation for the placing on the market of products containing, consisting of, or produced from genetically modified maize 1507 (DAS-Ø15Ø7-1) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council(14) is amended as follows.
(2) In Article 7 (authorisation holders)—
(a)for the heading substitute—
(b)for paragraphs 1 and 2 substitute—
“The authorisation holder is Corteva Agriscience LLC, United States of America, represented in Great Britain by Corteva Agriscience UK Limited.”
(3) In Article 9 (addressee), for the text substitute—
“This Decision is addressed to Corteva Agriscience LLC, 9330 Zionsville Road, Indianapolis, Indiana 46268-1054, United States of America, represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, CB21 5XE, United Kingdom.”
(4) In the Annex, for point (a) (applicants and authorisation holders) substitute—
“(a) Authorisation holder:
(1) The authorisation holder is Corteva Agriscience LLC, 9330 Zionsville Road, Indianapolis, Indiana 46268-1054, United States of America.
(2) The authorisation holder is represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, CB21 5XE, United Kingdom.”
Commencement Information
I15Reg. 15 in force at 26.4.2023, see reg. 1(2)(c)
16.—(1) Commission Implementing Decision (EU) 2018/1109 renewing the authorisation for the placing on the market of products containing, consisting of, or produced from genetically modified maize 59122 (DAS-59122-7) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council(15) is amended as follows.
(2) In Article 7 (authorisation holders)—
(a)for the heading substitute—
(b)for paragraphs 1 and 2 substitute—
“The authorisation holder is Corteva Agriscience LLC, United States of America, represented in Great Britain by Corteva Agriscience UK Limited.”
(3) In Article 9 (addressee), for the text substitute—
“This Decision is addressed to Corteva Agriscience LLC, 9330 Zionsville Road, Indianapolis, Indiana 46268-1054, United States of America, represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, CB21 5XE, United Kingdom.”
(4) In the Annex, for point (a) (applicants and authorisation holders) substitute—
“(a) Authorisation holder:
(1) The authorisation holder is Corteva Agriscience LLC, 9330 Zionsville Road, Indianapolis, Indiana 46268-1054, United States of America.
(2) The authorisation holder is represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, CB21 5XE, United Kingdom.”
Commencement Information
I16Reg. 16 in force at 26.4.2023, see reg. 1(2)(c)
17.—(1) Commission Implementing Decision (EU) 2018/1110 authorising the placing on the market of products containing, consisting of, or produced from genetically modified maize 1507 × 59122 × MON 810 × NK603, and genetically modified maize combining two or three of the single events 1507, 59122, MON 810 and NK603(16) is amended as follows.
(2) In Article 7 (authorisation holder), for the text substitute—
“The authorisation holder is Corteva Agriscience LLC, United States of America, represented in Great Britain by Corteva Agriscience UK Limited.”
(3) In Article 10 (addressee), for the text substitute—
“This Decision is addressed to Corteva Agriscience LLC, 9330 Zionsville Road, Indianapolis, Indiana 46268-1054, United States of America, represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, CB21 5XE, United Kingdom.”
(4) In the Annex, for point (a) (applicant and authorisation holder) substitute—
“(a) Authorisation holder:
(1) The authorisation holder is Corteva Agriscience LLC, 9330 Zionsville Road, Indianapolis, Indiana 46268-1054, United States of America.
(2) The authorisation holder is represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, CB21 5XE, United Kingdom.”
Commencement Information
I17Reg. 17 in force at 26.4.2023, see reg. 1(2)(c)
18.—(1) Commission Implementing Decision (EU) 2019/1304 authorising the placing on the market of products containing, consisting of or produced from genetically modified maize 4114 (DP-ØØ4114-3), pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council(17) is amended as follows.
(2) In Article 7 (authorisation holder), for the text substitute—
“The authorisation holder is Corteva Agriscience LLC, United States of America, represented in Great Britain by Corteva Agriscience UK Limited.”
(3) In Article 9 (addressee), for the text substitute—
“This Decision is addressed to Corteva Agriscience LLC, 9330 Zionsville Road, Indianapolis, Indiana 46268-1054, United States of America, represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, CB21 5XE, United Kingdom.”
(4) In the Annex, for point (a) (applicant and authorisation holder) substitute—
“(a) Authorisation holder:
(1) The authorisation holder is Corteva Agriscience LLC, 9330 Zionsville Road, Indianapolis, Indiana 46268-1054, United States of America.
(2) The authorisation holder is represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, CB21 5XE, United Kingdom.”
Commencement Information
I18Reg. 18 in force at 26.4.2023, see reg. 1(2)(c)
19.—(1) Commission Implementing Decision (EU) 2019/1306 renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified maize 1507 × NK603 (DAS-Ø15Ø7-1 × MON-ØØ6Ø3-6) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council(18) is amended as follows.
(2) In Article 7 (authorisation holders)—
(a)for the heading substitute—
(b)for paragraphs 1 and 2 substitute—
“The authorisation holder is Corteva Agriscience LLC, United States of America, represented in Great Britain by Corteva Agriscience UK Limited.”
(3) In Article 9 (addressees)—
(a)for the heading substitute—
(b)for the text substitute—
“This Decision is addressed to Corteva Agriscience LLC, 9330 Zionsville Road, Indianapolis, Indiana 46268-1054, United States of America, represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, CB21 5XE, United Kingdom.”
(4) In the Annex, for point (a) (applicants and authorisation holders) substitute—
“(a) Authorisation holder:
(1) The authorisation holder is Corteva Agriscience LLC, 9330 Zionsville Road, Indianapolis, Indiana 46268-1054, United States of America.
(2) The authorisation holder is represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, CB21 5XE, United Kingdom.”
Commencement Information
I19Reg. 19 in force at 26.4.2023, see reg. 1(2)(c)
20.—(1) Commission Implementing Decision (EU) 2019/2085 authorising the placing on the market of products containing, consisting of or produced from genetically modified maize MON 89034 × 1507 × NK603 × DAS-40278-9 and sub-combinations MON 89034 × NK603 × DAS-40278-9, 1507 × NK603 × DAS-40278-9 and NK603 × DAS-40278-9 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council(19) is amended as follows.
(2) In Article 7 (authorisation holder), for the text substitute—
“The authorisation holder is Corteva Agriscience LLC, United States of America, represented in Great Britain by Corteva Agriscience UK Limited.”
(3) In Article 9 (addressee), for the text substitute—
“This Decision is addressed to Corteva Agriscience LLC, 9330 Zionsville Road, Indianapolis, Indiana 46268-1054, United States of America, represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, CB21 5XE, United Kingdom.”
(4) In the Annex, for point (a) (applicant and authorisation holder) substitute—
“(a) Authorisation holder:
(1) The authorisation holder is Corteva Agriscience LLC, 9330 Zionsville Road, Indianapolis, Indiana 46268-1054, United States of America.
(2) The authorisation holder is represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, CB21 5XE, United Kingdom.”
Commencement Information
I20Reg. 20 in force at 26.4.2023, see reg. 1(2)(c)
21.—(1) Commission Implementing Decision (EU) 2019/2086 authorising the placing on the market of products containing, consisting of or produced from genetically modified maize MON 89034 × 1507 × MON 88017 × 59122 × DAS-40278-9 and genetically modified maize combining two, three or four of the single events MON 89034, 1507, MON 88017, 59122 and DAS-40278-9 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council(20) is amended as follows.
(2) In Article 7 (authorisation holder), for the text substitute—
“The authorisation holder is Corteva Agriscience LLC, United States of America, represented in Great Britain by Corteva Agriscience UK Limited.”
(3) In Article 9 (addressee), for the text substitute—
“This Decision is addressed to Corteva Agriscience LLC, 9330 Zionsville Road, Indianapolis, Indiana 46268-1054, United States of America, represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, CB21 5XE, United Kingdom.”
(4) In the Annex, for point (a) (applicant and authorisation holder) substitute—
“(a) Authorisation holder:
(1) The authorisation holder is Corteva Agriscience LLC, 9330 Zionsville Road, Indianapolis, Indiana 46268-1054, United States of America.
(2) The authorisation holder is represented in Great Britain by Corteva Agriscience UK Limited, Cpc2 Capital Park, Fulbourn, Cambridge, CB21 5XE, United Kingdom.”
Commencement Information
I21Reg. 21 in force at 26.4.2023, see reg. 1(2)(c)
22. Commission Decision 2010/429/EU authorising the placing on the market of products containing, consisting of, or produced from genetically modified maize MON 88017 × MON 810 (MON-88Ø17-3 × MON-ØØ81Ø-6) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council(21) is revoked.
Commencement Information
I22Reg. 22 in force at 26.4.2023, see reg. 1(2)(c)
Lynne Neagle
Deputy Minister for Mental Health and Wellbeing, under the authority of the Minister for Health and Social Services, one of the Welsh Ministers
28 March 2023
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area. The revised version is currently only available in English.
Original (As Enacted or Made) - English: The original English language version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Original (As Enacted or Made) - Welsh:The original Welsh language version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: